Cardiac Risk Stratification for Non-Invasive Procedures

Procedure Risk Classification

Colonoscopy is classified as a low-risk procedure with cardiac risk <1% for death or myocardial infarction, similar to endoscopic and superficial procedures, according to the American College of Cardiology and American Heart Association guidelines 1, 3
Low-risk procedures rarely require extensive preoperative cardiac testing regardless of patient risk factors, as stated by the American College of Cardiology and American Heart Association guidelines 1, 2
The American College of Cardiology and American Heart Association guidelines explicitly state that routine perioperative evaluation of LV function is not recommended (Class III recommendation, Level of Evidence B) 1, 3

An ejection fraction of 48% falls into the heart failure with mildly reduced ejection fraction category (41-49%) according to the 2022 American Heart Association and American College of Cardiology guidelines 4, 5
This ejection fraction is above the critical threshold of <35-40% where perioperative cardiac complications significantly increase, as indicated by the American College of Cardiology and American Heart Association guidelines 1, 2

The American College of Cardiology and American Heart Association guidelines provide specific Class IIa recommendations for LV function evaluation, including dyspnea of unknown origin and current or prior heart failure with worsening dyspnea or clinical status change 1, 2, 3
Patients with unstable coronary syndromes, decompensated heart failure, significant arrhythmias, or severe valvular disease require evaluation, as stated by the American College of Cardiology and American Heart Association guidelines 7
The American College of Cardiology and American Heart Association guidelines recommend that asymptomatic patients with an ejection fraction of 48% proceed directly to colonoscopy without additional cardiac testing 1, 2, 3

The American Heart Association and American College of Cardiology guidelines recommend ensuring patients continue guideline-directed medical therapy for heart failure with mildly reduced ejection fraction through the perioperative period 4, 5
Beta-blockers should be continued if already prescribed, according to the American College of Cardiology and American Heart Association guidelines 2

Standard monitoring (pulse oximetry, blood pressure) is sufficient, as recommended by the American College of Cardiology and American Heart Association guidelines 1
No routine ECG monitoring is required unless the patient has a history of significant arrhythmias, according to the American College of Cardiology and American Heart Association guidelines 1, 2, 3